← Back to headlines
ImmunityBio Reaches New High on Anktiva Expansion Prospects
ImmunityBio (IBRX) stock soared to a new high, driven by optimism surrounding the future expansion of its drug Anktiva.
19 Feb, 11:08 — 19 Feb, 11:08
Read at source (1 outlet)
Related Stories
Guanajuato's Airport Undergoing 2.88 Billion-Peso Facelift
9m ago
Mexico Considers 'Sustainable Fracking' to Reduce U.S. Natural Gas Dependence
9m ago
Nord Precious Metals Mining Inc. to Participate in Red Cloud's Pre-PDAC Mining Showcase
9m ago
Beeline Holdings Appoints Barry Levenson as Executive Strategic Advisor
9m ago